...
首页> 外文期刊>World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons >Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.
【24h】

Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.

机译:优化肝移植作为部分肝切除术后肝内肝细胞癌复发的治疗:一个欧洲系列的经验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The aim of this study was to ascertain the outcome of liver transplantation (LT) due to hepatocellular carcinoma (HCC) in patients who had undergone previous liver resection (LR) for HCC. METHODS: A case-control study (1:2) was designed to compare patients who underwent LT due to HCC recurrence with a previous LR for HCC (study group) with those who underwent LT for primary HCC but without previous LR (control group). RESULTS: From January 1990 to December 2007, a total of 303 cirrhotic patients with primary HCC were evaluated for surgery. Primary LT was performed in 191 and LR in 100. When HCC recurrence was diagnosed after LR (69/100), 17 of the 69 (25%) patients underwent LT (study group). The median follow-up was 70 months (12.7-203.0 months). Disease-free survivals at 1, 3, and 5 years in the study group versus the control group were 86%, 68%, 58% vs. 97%, 93%, 89%, respectively (p < 0.04). The 1-, 3-, and 5-year actuarial patient survivals in the study group versus the control group were 59%, 52%, 52% vs. 85%, 76%, 65%, respectively (p = NS). Patients of the study group were divided into two groups according to the time to recurrence after LR: group 1 was <1 year, and group 2 was >1 year. Recurrence after LT was 75% in group 1 vs. 15.4% in group 2 (p < 0.03). The 1-, 3-, and 5-year actuarial patient survivals were 25%, 0%, 0% in group 1 and 69%, 69%, 69% in group 2, p < 0.02). CONCLUSIONS: Liver transplantation can be safely performed after a previous LR for HCC. Patients with recurrence during the first year after hepatectomy have a poor prognosis after LT.
机译:背景:本研究的目的是确定先前接受过肝癌切除术(LR)的肝细胞癌(HCC)患者的肝移植(LT)结果。方法:设计了一项病例对照研究(1:2),将因肝癌复发而接受LT的患者与既往曾接受过HCC的LR的患者(研究组)与接受过LT接受原发性HCC但未接受过LR的患者(对照组)进行比较。 。结果:从1990年1月至2007年12月,共303例原发性肝癌肝硬化患者接受了手术评估。原发性LT在191例中进行,而LR在100例中进行。当在LR(69/100)后诊断出HCC复发时,在69例患者中有17例(25%)接受了LT(研究组)。中位随访时间为70个月(12.7-203.0个月)。与对照组相比,研究组在1年,3年和5年的无病生存率分别为86%,68%,58%和97%,93%,89%(p <0.04)。研究组与对照组的1年,3年和5年精算患者存活率分别为59%,52%,52%和85%,76%,65%(p = NS)。根据LR术后复发的时间,将研究组的患者分为两组:第一组为<1年,第二组为> 1年。第1组LT后的复发率为75%,而第2组为15.4%(p <0.03)。第一组的1年,3年和5年的精算患者生存率分别为25%,0%,0%,第2组为69%,69%,69%,p <0.02)。结论:先前的肝癌肝移植术后可以安全地进行肝移植。肝切除术后第一年复发的患者LT术后预后较差。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号